Table 2.
ATA Risk Stratification | |
---|---|
PTC (with all of the following): | |
No local or distant metastases | |
All macroscopic tumor has been resected | |
No tumor invasion of loco-regional tissues or structures | |
The tumor does not have aggressive histology (e.g., tall cell, hobnail variant, columnar cell carcinoma) | |
If I-131 is given, there are no RAI-avid metastatic foci outside the thyroid bed on the first post-treatment whole-body RAI scan | |
No vascular invasion | |
Clinical N0 or ≤five pathologic N1 micrometastases (<0.2 cm in largest dimension) | |
Intrathyroidal, encapsulated follicular variant of PTC | |
Intrathyroidal, well-differentiated follicular thyroid cancer with capsular invasion and no or minimal (<four foci) vascular invasion | |
Intrathyroidal, papillary microcarcinoma, unifocal, or multifocal, including BRAF V600E mutated (if known) |
Data from Haugen et al. (8).
Abbreviations: I-131, iodine-131; N0, no evidence of regional lymph node metastasis; N1, metastases to cervical/upper mediastinal lymph nodes.